Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Shi's Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
J Orthop Traumatol. 2022 Jul 11;23(1):31. doi: 10.1186/s10195-022-00648-5.
Haemophilic arthropathy (HA), a common complication of haemophilia, is secondary to recurrent joint bleeding and increases the prevalence of end-stage osteoarthritis (OA). Total knee arthroplasty (TKA) is a reliable treatment for haemophilia patients. This study was performed to evaluate the mid-term outcomes of TKA for end-stage HA. We hypothesized that the rate of complications of TKA is higher for patients with haemophilia than for patients without haemophilia.
Patients with HA undergoing TKA from January 2015 to December 2016 in our centre were retrospectively reviewed. All patients were managed by a multidisciplinary team. The improvements in flexion contracture, range of motion (ROM), Knee Society Score (KSS; clinical and functional), Visual Analogue Scale (VAS) score, and satisfaction at final follow-up were analysed to evaluate the effectiveness of TKA in HA. The complications were analysed to evaluate the safety of TKA in HA.
Twenty-eight patients (32 knees) were included in the study. The follow-up was 69.1 ± 5.1 months. Significant differences between the preoperative and final follow-up values of flexion contracture (which changed from 21.1 ± 6.5° to 14.3 ± 4.1°, P < 0.001), ROM (from 53.9 ± 15.0° to 70.3 ± 16.3°, P < 0.001), clinical KSS (from 33.5 ± 14.4° to 62.7 ± 9.5°, P < 0.001), functional KSS (from 46.1 ± 15.5° to 62.9 ± 9.7°, P < 0.001), and VAS score (from 6.8 ± 1.4 to 4.9 ± 1.3, P < 0.01) were observed. Importantly, the incidence of complications was 15.6% and the satisfaction was 100% in our mid-term study.
Under elaborative and comprehensive management, TKA is effective and safe in patients with advanced HA on the basis of mid-term follow-up outcomes.
血友病性关节病(HA)是血友病的常见并发症,继发于反复关节出血,增加了终末期骨关节炎(OA)的患病率。全膝关节置换术(TKA)是血友病患者的可靠治疗方法。本研究旨在评估 TKA 治疗终末期 HA 的中期结果。我们假设 TKA 治疗血友病患者的并发症发生率高于非血友病患者。
回顾性分析了 2015 年 1 月至 2016 年 12 月在我院接受 TKA 的 HA 患者。所有患者均由多学科团队管理。分析 TKA 治疗 HA 后膝关节活动度(ROM)、膝关节学会评分(KSS;临床和功能)、视觉模拟评分(VAS)和最终随访时的满意度的改善情况,以评估 TKA 的有效性。分析并发症以评估 TKA 在 HA 中的安全性。
本研究纳入了 28 例(32 膝)患者。随访时间为 69.1±5.1 个月。术前和末次随访时膝关节屈曲挛缩(从 21.1±6.5°变为 14.3±4.1°,P<0.001)、ROM(从 53.9±15.0°变为 70.3±16.3°,P<0.001)、临床 KSS(从 33.5±14.4°变为 62.7±9.5°,P<0.001)、功能 KSS(从 46.1±15.5°变为 62.9±9.7°,P<0.001)和 VAS 评分(从 6.8±1.4 变为 4.9±1.3,P<0.01)有显著差异。重要的是,在我们的中期研究中,并发症发生率为 15.6%,满意度为 100%。
在精心和全面的管理下,根据中期随访结果,TKA 对晚期 HA 患者是有效和安全的。